Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Medicine|February 9, 2006
Pro-inflammatory signaling by Jun-N-terminal kinase in inflammatory bowel diseaseKeiichi Mitsuyama, Asuka Suzuki, Nobuo Tomiyasu, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2007
Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-Jun NH2 terminal kinase inhibitor SP600125Alison S Williams, Razao Issa, Sum Yee Leung, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 7, 2010
JNK signalling in human and experimental renal ischaemia/reperfusion injuryJohn Kanellis, Frank Y Ma, Rangi Kandane-Rathnayake, et al.
American Journal of Nephrology|August 31, 2011
Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive ratsAndy K H Lim, Frank Y Ma, David J Nikolic-Paterson, et al.
Blood|May 7, 2009
Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPasesYibing Xu, Jianwu Li, Gregory D Ferguson, et al.
Journal of the American Society of Nephrology : JASN|January 5, 2007
A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosisFrank Y Ma, Robert S Flanc, Greg H Tesch, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
The design and synthesis of novel orally active inhibitors of AP-1 and NF-kappaB mediated transcriptional activation. SAR of in vitro and in vivo studiesMoorthy S S Palanki, Paul E Erdman, Minghuan Ren, et al.
Annals of the Rheumatic Diseases|January 20, 2012
Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosisNicole Reich, Michal Tomcik, Pawel Zerr, et al.
Pageof 3